# The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020, Regulation 29: Amendment of regulation 345

Extent: E+W+S+N.I.

In regulation 345 (immunity from civil liability), in paragraph (3)—
(a) after sub-paragraph (a) insert—
“(aa) if there is no holder of an authorisation for the product but the sale or supply of the product is authorised by the licensing authority on a temporary basis under regulation 174, the person responsible for placing the product on the market in the United Kingdom;”;
(b) in sub-paragraph (c), for “paragraph (a) or (b); or” substitute “ sub-paragraph (a), (aa) or (b); ”;
(c) insert “ ; or ” at the end of sub-paragraph (d); and
(d) after sub-paragraph (d) insert—
“(e) any person, not being a health care professional, who administers the product in accordance with a protocol of the type mentioned in regulation 247A.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1125/regulation/29 (the official version)
Page: https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020/regulation-29
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.